Cellectis SA (CLLS)
3.41
+0.03
(+0.89%)
USD |
NASDAQ |
Apr 02, 16:00
3.49
+0.08
(+2.35%)
After-Hours: 20:00
Cellectis Profit Margin (Quarterly) : -253.1% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| DBV Technologies SA | -- |
| EDAP TMS SA | -43.22% |
| Sanofi | -- |
| Akari Therapeutics Plc | -- |
| Biodexa Pharmaceuticals Plc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -65.19% |
| Return on Assets | -19.02% |
| Return on Invested Capital | -31.08% |
| Gross Profit Margin (Quarterly) | 50.92% |
| Operating Margin (Quarterly) | -181.2% |
| Return on Net Operating Assets | -82.68% |